Technology | January 20, 2010

High-Pressure Balloon Introduced for Challenging Peripheral Lesions


January 20, 2010 – The balloon material of the new REEF HP PTA Balloon Catheter was created for use in peripheral high-pressure dilatation procedures, especially to treat hard-to-dilate lesions. The balloon received FDA 510(k) clearance this week.

Invatec said its new balloon can treat a range of peripheral lesions, including dialysis patients whose arteriovenous shunts often create fibrous and hard-to-dilate lesions.

The REEF HP balloon is made from Flexitec XF, an extremely durable material with a large working pressure range of up to 22 atm. The low compliant balloon offers a uniform dilatation force and strong shape retention to dilate resistive lesions with greater stability and success. Its low-profile design enables consistent delivery and ease of crossability. The balloon is available in a wide range of sizes, from diameters of 4-8 mm and lengths of 20-80 mm.

“We often encounter calcified and resistant lesions in peripheral vessels and in hemodialysis access interventions,” said Robert L. Vogelzang, M.D., professor of radiology at Northwestern University Medical School and chief of vascular and interventional radiology at Northwestern Memorial Hospital. “Invatec’s addition of a high pressure PTA balloon will aid in the successful treatment of these challenging lesions.”

For more information: www.invatec.com


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now